Heron Therapeutics, Inc. (LON:0J4V)

Heron Therapeutics Statistics

Total Valuation

LON:0J4V has a market cap or net worth of GBP 154.80 million. The enterprise value is 222.94 million.

Market Cap	154.80M
Enterprise Value	222.94M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	183.36M
Shares Outstanding	n/a
Shares Change (YoY)	+3.91%
Shares Change (QoQ)	+10.60%
Owned by Insiders (%)	0.72%
Owned by Institutions (%)	57.34%
Float	132.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.34
PB Ratio	13.98
P/TBV Ratio	29.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.77, with an EV/FCF ratio of -9.62.

EV / Earnings	-22.07
EV / Sales	1.96
EV / EBITDA	52.77
EV / EBIT	190.16
EV / FCF	-9.62

Financial Position

The company has a current ratio of 2.56, with a Debt / Equity ratio of 9.44.

Current Ratio	2.56
Quick Ratio	1.52
Debt / Equity	9.44
Debt / EBITDA	24.40
Debt / FCF	-4.51
Interest Coverage	0.21

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	0.42%
Return on Invested Capital (ROIC)	0.68%
Return on Capital Employed (ROCE)	1.00%
Weighted Average Cost of Capital (WACC)	8.32%
Revenue Per Employee	945,761
Profits Per Employee	-82,797
Employee Count	122
Asset Turnover	0.66
Inventory Turnover	0.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.64% in the last 52 weeks. The beta is 1.25, so LON:0J4V's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	-28.64%
50-Day Moving Average	1.33
200-Day Moving Average	1.56
Relative Strength Index (RSI)	38.51
Average Volume (20 Days)	20,174

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	20.46

Income Statement

In the last 12 months, LON:0J4V had revenue of GBP 115.38 million and -10.10 million in losses. Loss per share was -0.06.

Revenue	115.38M
Gross Profit	76.46M
Operating Income	1.19M
Pretax Income	-10.10M
Net Income	-10.10M
EBITDA	2.94M
EBIT	1.19M
Loss Per Share	-0.06

Balance Sheet

The company has 41.28 million in cash and 104.48 million in debt, with a net cash position of -63.20 million.

Cash & Cash Equivalents	41.28M
Total Debt	104.48M
Net Cash	-63.20M
Net Cash Per Share	n/a
Equity (Book Value)	11.07M
Book Value Per Share	0.03
Working Capital	103.92M

Cash Flow

In the last 12 months, operating cash flow was -22.46 million and capital expenditures -710,463, giving a free cash flow of -23.17 million.

Operating Cash Flow	-22.46M
Capital Expenditures	-710,463
Free Cash Flow	-23.17M
FCF Per Share	n/a

Margins

Gross margin is 66.27%, with operating and profit margins of 1.03% and -8.75%.

Gross Margin	66.27%
Operating Margin	1.03%
Pretax Margin	-8.75%
Profit Margin	-8.75%
EBITDA Margin	2.55%
EBIT Margin	1.03%
FCF Margin	n/a

Dividends & Yields

LON:0J4V does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.91%
Shareholder Yield	-3.91%
Earnings Yield	-6.53%
FCF Yield	-14.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0J4V has an Altman Z-Score of -8.87 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.87
Piotroski F-Score	5